Skip to Main Content

Author Details

Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
1996
130
39
PMIDPaper TitleJournal TitlePublished Year
36576700H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis.Cell Oncol (Dordr)2023
37481512Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data.BMC Bioinformatics2023
37088463Quantile Index Biomarkers Based on Single-Cell Expression Data.Lab Invest2023
36652667High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer.JCO Precis Oncol2023
36645549Correction to: H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis.Cell Oncol (Dordr)2023
34961733Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.Clin Breast Cancer2022
35530653Circulating Cell-free DNA in Serum as a Marker for the Early Detection of Tumor Recurrence in Breast Cancer Patients.Cancer Diagn Progn2022
35784745Cisplatin Promotes the Efficacy of Immune Checkpoint Inhibitor Therapy by Inducing Ferroptosis and Activating Neutrophils.Front Pharmacol2022
35657686Long noncoding RNA OVAAL enhances nucleotide synthesis through pyruvate carboxylase to promote 5-fluorouracil resistance in gastric cancer.Cancer Sci2022
35355868Regulation of ACSL4-Catalyzed Lipid Peroxidation Process Resists Cisplatin Ototoxicity.Oxid Med Cell Longev2022
35414004Potential of RNA-binding protein human antigen R as a driver of osteogenic differentiation in osteoporosis.J Orthop Surg Res2022
36209516LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression.Redox Biol2022
36384096Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways.Cell Rep Med2022
35041696Assessing the quality of RNA isolated from human breast tissue after ambient room temperature exposure.PLoS One2022
35326599A Novel Blood-Based microRNA Diagnostic Model with High Accuracy for Multi-Cancer Early Detection.Cancers (Basel)2022
35053472Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer.Cancers (Basel)2022
34965935LncRNA Uc003xsl.1-Mediated Activation of the NFκB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer.Cancer Res2022
33421618Non-coding RNAs rewire cancer metabolism networks.Semin Cancer Biol2021
33637716The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis.Nat Commun2021
35036865Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry.iScience2021
34992825Neoadjuvant camrelizumab, nab-paclitaxel, and carboplatin in patients with stage IB-IIIA non-small cell lung cancer (NANE-LC): a study protocol of prospective, single-arm, multicenter, phase II study.J Thorac Dis2021
33171529PD-L1 versus tumor mutation burden: Which is the better immunotherapy biomarker in advanced non-small cell lung cancer?J Gene Med2021
32193285Inactivation of the Prolyl Isomerase Pin1 Sensitizes BRCA1-Proficient Breast Cancer to PARP Inhibition.Cancer Res2020
32074342Proteomic Analysis of Inflammatory Biomarkers Associated With Breast Cancer Recurrence.Mil Med2020
33211735Functional role of vitronectin in breast cancer.PLoS One2020
33292179Comparative analysis of differentially abundant proteins quantified by LC-MS/MS between flash frozen and laser microdissected OCT-embedded breast tumor samples.Clin Proteomics2020
32744311Corrigendum to: Proteomic Analysis of Inflammatory Biomarkers Associated With Breast Cancer Recurrence.Mil Med2020
32999837Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 Silencing to Block Wnt/<i>β</i>-Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy.Adv Sci (Weinh)2020
32880016Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer.Breast Cancer Res Treat2020
32959585[Acupuncture based on meridian diagnosis for chronic atrophic gastritis].Zhongguo Zhen Jiu2020
32869577[Analysis of the clinical effect on post-stroke shoulder hand syndrome stage â¿  treated with the along-meridian trochar acupuncture therapy].Zhen Ci Yan Jiu2020
32721893High salt diet may promote progression of breast tumor through eliciting immune response.Int Immunopharmacol2020
32530468Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants.JAMA Netw Open2020
32508054Joint association of patients' sex and PD-L1 expression with overall survival benefits and tumor-immune microenvironment in immune checkpoint inhibitors for cancers.Clin Transl Med2020
32508050Novel blood-based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non-small-cell lung cancer: Results from two multicenter, randomized clinical trials.Clin Transl Med2020
32521278Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade.Cell Rep2020
32378445Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancers.Cancer Biol Ther2020
32193458Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer.Nat Commun2020
30901475Serum Biomarkers for Racial Disparities in Breast Cancer Progression.Mil Med2019
30838639From Discovery to Practice and Survivorship: Building a National Real-World Data Learning Healthcare Framework for Military and Veteran Cancer Patients.Clin Pharmacol Ther2019
30890553Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.Clin Cancer Res2019
31165373Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.Breast Cancer Res Treat2019
31138829PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B.Sci Rep2019
30755777Lung Function Decline after 24 Weeks of Moxa Smoke Exposure in Rats.Evid Based Complement Alternat Med2019
29247440Analysis of breast cancer in young women in the Department of Defense (DOD) database.Breast Cancer Res Treat2018
32185953Repeated exposure to moxa-burning smoke: its acute and chronic toxicities in rats.J Tradit Chin Med2018
30097435Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.Clin Cancer Res2018
30374420<i>Fusobacterium</i> and Colorectal Cancer.Front Oncol2018
30522107β-Elemene Inhibits Human Sperm Function by Affecting Sperm Vitality and Intracellular Calcium.Cell Physiol Biochem2018
29476791An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.Cancer Lett2018
  • 1 - 50 of 130

Recommended Authors

Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 1
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 1
Qilu Hospital of Shandong University
Career Start Year 2011
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 10
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 4
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 2
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 0
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 2
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 1
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 0
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 2
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 5
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 14
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 2
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 7
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 2
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 5
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 17
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 7

Collaborators

Walter Reed National Military Medical Center
Co-authored papers 41
Peking University Third Hospital
Co-authored papers 12
Co-authored papers 10
Iowa State University
Co-authored papers 10
Windber Research Institute
Co-authored papers 9
Chan Soon-Shiong Institute of Molecular Medicine at Windber
Co-authored papers 8
the Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Co-authored papers 5
Co-authored papers 5
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Co-authored papers 4
Dana-Farber Cancer Institute
Co-authored papers 4
Co-authored papers 4
Co-authored papers 3
Women's Health Integrated Research Center, Inova Health System
Co-authored papers 3
Women's Health Integrated Research Center, Inova Health System
Co-authored papers 3
Uniformed Services University of the Health Sciences
Co-authored papers 3
Peking University Cancer Hospital
Co-authored papers 2
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2
Co-authored papers 2
College of Life Sciences, Sichuan University
Co-authored papers 2
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 2
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Co-authored papers 2
Boston Children's Hospital
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Buck Institute for Research on Aging
Co-authored papers 2
Center for Trauma and Acute Care Surgery Research, Clinical Services Group
Co-authored papers 2
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
Thomas Jefferson University Hospital
Co-authored papers 2
Uniformed Services of the Health Sciences Gynecologic Cancer Center of Excellence
Co-authored papers 2